Literature DB >> 6781917

Trypanosoma cruzi: allopurinol in the treatment of mice with experimental acute Chagas disease.

J L Avila, A Avila.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6781917     DOI： 10.1016/0014-4894(81)90109-0

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN： 0014-4894            Impact factor:   2.011


× No keyword cloud information.
  17 in total

1.  Clinical aspects of Chagas disease and implications for novel therapies.

Authors:  Cristiane Menezes; Germano Carneiro Costa; Kenneth J Gollob; Walderez O Dutra
Journal:  Drug Dev Res       Date:  2011-09       Impact factor: 4.360

2.  Darwin's illness: Chagas' disease resurgens.

Authors:  R E Bernstein
Journal:  J R Soc Med       Date:  1984-07       Impact factor: 5.344

3.  Activity of P536, a UDP-glucose analog, against Trypanosoma cruzi.

Authors:  A Alcina; M Fresno; B Alarcón
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

4.  Treatment of chronic experimental Trypanosoma cruzi infections in mice with MK-436, a 2-substituted 5-nitroimidazole.

Authors:  S G Andrade; R C Silva; C M Santiago
Journal:  Bull World Health Organ       Date:  1989       Impact factor: 9.408

Review 5.  Human antiprotozoal therapy: past, present, and future.

Authors:  M Khaw; C B Panosian
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

Review 6.  Chagas' disease.

Authors:  H B Tanowitz; L V Kirchhoff; D Simon; S A Morris; L M Weiss; M Wittner
Journal:  Clin Microbiol Rev       Date:  1992-10       Impact factor: 26.132

7.  Effect of allopurinol on Trypanosoma cruzi: metabolism and biological activity in intracellular and bloodstream forms.

Authors:  R L Berens; J J Marr; F S Steele da Cruz; D J Nelson
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191

8.  Sequential combined treatment with allopurinol and benznidazole in the chronic phase of Trypanosoma cruzi infection: a pilot study.

Authors:  D E Perez-Mazliah; M G Alvarez; G Cooley; B E Lococo; G Bertocchi; M Petti; M C Albareda; A H Armenti; R L Tarleton; S A Laucella; R Viotti
Journal:  J Antimicrob Chemother       Date:  2012-10-26       Impact factor: 5.790

9.  In vitro and in vivo activities of formycin B against Trypanosoma cruzi.

Authors:  R E McCabe; J S Remington; F G Araujo
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

10.  A convenient synthesis of 6-amino-1-beta-D-ribofuranosylpyrazolo[3,4-d]pyrimidin-4-one and related 4,6-disubstituted pyrazolopyrimidine nucleosides.

Authors:  H B Cottam; G R Revankar; R K Robins
Journal:  Nucleic Acids Res       Date:  1983-02-11       Impact factor: 16.971
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.